The results of serum sample testing showed that these mAbs, as described above, specifically identified the proteins S100A8, S100A9 and S100A12 in the serum and were able to evaluate changes in the protein content of S100A8, S100A9, and S100A12 during infection. The gene discussed is S100A12; the disease is infection.